Baidu-(NASDAQ-BIDU), a Chinese language internet search provider, is recently up $4.00 to $324 in pre-open trading. The company will report earnings on 10/25. Smith Barney has a $250 price target. November option implied volatility of 89 is above its 26-week average of 56 according to Track Data, suggesting larger price fluctuations.

Vertex Pharma-(NASDAQ-VRTX), is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. The company sold off on 10/18/07 after promising trial data from Schering Plough's-(NYSE-SGP) Hepatitis C drug boceprevir was seen as a threat to VRTX's Telaprevir. Option volume was heavy on 54,154 contracts. November option implied volatility of 75 is above its 26-week average of 48 according to Track Data, suggesting larger price fluctuations.

Daily options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Option update 10-19-07: Baidu volatility Elevated at 90 into EPS originally appeared on BloggingStocks on Fri, 19 Oct 2007 08:45:00 EST. Please see our terms for use of feeds.